Page last updated: 2024-08-23

zidovudine and kni-727

zidovudine has been researched along with kni-727 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Matsumoto, H; Ota, H; Sano, K1
Camarasa, MJ; de Castro, S1
Goto, T; Hamawaki, T; Hayashi, Y; Kimura, T; Kiso, Y; Kumagai, A; Matsumoto, H; Sano, K1

Reviews

1 review(s) available for zidovudine and kni-727

ArticleYear
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
    European journal of medicinal chemistry, 2018, Apr-25, Volume: 150

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Polypharmacology

2018

Other Studies

2 other study(ies) available for zidovudine and kni-727

ArticleYear
'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker.
    Bioorganic & medicinal chemistry letters, 2000, Jun-05, Volume: 10, Issue:11

    Topics: Anti-HIV Agents; HIV Protease Inhibitors; HIV-1; Humans; Microbial Sensitivity Tests; Prodrugs; Reverse Transcriptase Inhibitors; Thiazoles; Zidovudine

2000
Design, synthesis, and biological evaluation of anti-HIV double-drugs. conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor through spontaneously cleavable linkers.
    Bioorganic & medicinal chemistry, 2001, Volume: 9, Issue:6

    Topics: Animals; Anti-HIV Agents; Drug Design; Drug Evaluation, Preclinical; HIV Protease Inhibitors; Humans; Prodrugs; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured; Zidovudine

2001